Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 5 Insider Annual Insider Trading Report
  2. 4 Open-market buy Chief Executive Officer bought 35,000 shares at $0.68 ($23,800)
  3. 4 Open-market buy Director bought 5,500 shares at $0.89 ($4,895)
  4. 4 Open-market buy Director bought 5,391 shares at $0.93 ($4,997)
  5. 4 Open-market buy Chief Medical Officer bought 20,000 shares at $1.03 ($20,600)
  6. 4 Open-market buy Director bought 4,500 shares at $1.06 ($4,770)
  7. 4 Open-market buy Director bought 5,350 shares at $0.94 ($5,029)
  8. 4 Open-market buy Chief Executive Officer bought 60,000 shares at $0.91 ($54,600)
  9. 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,100)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 19 · 376 filings